MIRA device imaging
Sponsors
Real Imaging Ltd.
Conditions
Breast Cancer
Unknown Phase
Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System
NCT02155075
Start: 2015-01-31End: 2019-10-31Target: 730Updated: 2018-06-19
Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer
TerminatedNCT02777164
Start: 2016-05-31End: 2018-10-31Updated: 2019-05-03
Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer
NCT03080155
Start: 2016-09-30End: 2018-10-31Target: 680Updated: 2018-06-19
Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer
NCT03296683
Start: 2017-05-23End: 2021-09-30Target: 1200Updated: 2018-06-19